LigaChem Biosciences Inc. (KOSDAQ:141080)

LigaChem Biosciences Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
Cash & Equivalents	108,360	128,912	63,054	117,965	139,940	66,888
Short-Term Investments	359,892	365,035	36,871	51,981	40,874	27,873
Cash & Short-Term Investments	468,253	493,947	99,925	169,946	180,814	94,762
Cash Growth	-30.69%	394.32%	-41.20%	-6.01%	90.81%	32.66%
Accounts Receivable	44,072	13,717	14,809	12,780	22,457	11,120
Other Receivables	13,294	14,713	4,347	6,404	23,827	478.82
Receivables	57,486	28,543	19,156	19,184	46,284	11,699
Inventory	227.51	212.47	196.83	198.82	270.55	2,021
Prepaid Expenses	2,540	1,891	785.42	688.15	1,233	737.66
Other Current Assets	10,406	25,668	14,555	1,602	349.11	2,200
Total Current Assets	538,912	550,262	134,619	191,619	228,951	111,419
Property, Plant & Equipment	27,704	25,313	25,424	26,492	24,432	12,144
Long-Term Investments	34,860	46,130	17,340	19,825	22,631	7,326
Goodwill	20,092	-	-	-	-	-
Other Intangible Assets	8,436	8,442	6,901	7,889	8,601	8,988
Long-Term Deferred Tax Assets	337.64	338.44	981.16	-	-	-
Other Long-Term Assets	109,495	107,898	4,143	6,610	8,619	1,600
Total Assets	739,838	738,383	189,502	252,530	293,233	141,477
Accounts Payable	6,471	7,688	7,095	7,285	6,846	7,692
Accrued Expenses	11,500	8,952	11,268	3,764	417.57	364.32
Short-Term Debt	-	-	11,847	2,700	-	-
Current Portion of Long-Term Debt	-	-	-	9,147	2,700	-
Current Portion of Leases	876.48	480.53	268.56	185.81	158.2	111.18
Current Income Taxes Payable	46.09	46.2	-	-	-	-
Current Unearned Revenue	3,671	4.6	5.5	12.48	39.67	1,626
Other Current Liabilities	78,777	100,011	6,588	5,508	6,857	5,631
Total Current Liabilities	101,342	117,183	37,072	28,603	17,018	15,424
Long-Term Debt	-	-	-	-	9,147	1,900
Long-Term Leases	1,452	339.34	528.37	216.4	263.35	174
Long-Term Deferred Tax Liabilities	-	-	-	1,129	3,928	2,881
Other Long-Term Liabilities	57,829	418.28	316.02	378.15	468.07	1,267
Total Liabilities	170,459	122,385	41,281	32,932	34,459	25,568
Common Stock	18,305	18,305	14,060	12,752	12,117	5,361
Additional Paid-In Capital	264,465	571,840	97,523	93,881	349,792	185,180
Retained Earnings	311,796	36,331	30,740	105,383	-109,586	-78,812
Treasury Stock	-27,757	-24,835	-4,879	-	-	-
Comprehensive Income & Other	16,507	14,357	10,626	6,501	4,945	1,377
Total Common Equity	583,316	615,998	148,071	218,516	257,268	113,106
Minority Interest	-13,936	-	-	-	-	2,160
Shareholders' Equity	569,380	615,998	148,221	219,599	258,775	115,909
Total Liabilities & Equity	739,838	738,383	189,502	252,530	293,233	141,477
Total Debt	2,329	819.87	12,644	12,249	12,269	2,185
Net Cash (Debt)	465,924	493,128	87,281	157,697	168,545	92,576
Net Cash Growth	-29.78%	464.99%	-44.65%	-6.44%	82.06%	29.61%
Net Cash Per Share	12631.40	14189.19	3072.85	5628.72	6986.35	3855.44
Filing Date Shares Outstanding	36.26	36.28	27.98	25.5	24.23	21.44
Total Common Shares Outstanding	36.26	36.28	27.98	25.5	24.23	21.44
Working Capital	437,570	433,079	97,547	163,016	211,933	95,995
Book Value Per Share	16085.16	16978.06	5291.96	8568.24	10615.60	5274.52
Tangible Book Value	554,787	607,556	141,169	210,627	248,667	104,118
Tangible Book Value Per Share	15298.47	16745.38	5045.31	8258.90	10260.69	4855.36
Land	2,815	2,815	2,815	2,815	2,815	2,591
Buildings	16,191	16,188	16,134	16,119	16,104	2,559
Machinery	19,015	16,148	13,824	13,135	9,060	9,779
Construction In Progress	177	177	-	184.65	174	2,577

Source: S&P Global Market Intelligence. Standard template. Financial Sources.